Computational Screening of PBDEs Binding to Enoyl-ACP Reductase
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the binding activities of polybrominated diphenyl ethers (PBDEs) derivatives to enoyl-ACP reductase are time-consuming and lack accuracy, necessitating a faster and more efficient approach.
Innovation Solution
A method involving the construction of a ligand-receptor protein complex using modified enoyl-ACP reductase, molecular docking, and molecular dynamic simulation to assess binding activities, including structure optimization, docking, and analysis of hydrogen bond and π-π stacking interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional experimental methods are used to determine binding activities of PBDEs derivatives to enoyl-ACP reductase, then measurement reliability is maintained, but time consumption increases and productivity decreases
Solution Approach 1:
The patent creates a computational copy of the binding interaction system by building a ligand-receptor protein complex model. Molecular docking and molecular dynamic simulations replicate the experimental binding process in silico, allowing multiple PBDEs derivatives to be screened simultaneously without performing repeated wet-lab experiments, thus dramatically improving productivity while maintaining measurement reliability through validated simulation protocols
Solution Approach 2:
The patent performs preliminary structure optimization and conformational analysis before the actual binding activity determination. By pre-optimizing ligand and receptor structures, generating initial docking poses, and preparing the simulation system in advance, the method eliminates time-consuming setup steps during the actual screening process, enabling faster determination of binding activities for multiple derivatives
2Measurement precision
If traditional experimental methods are used to determine binding activities of PBDEs derivatives to enoyl-ACP reductase, then measurement reliability is maintained, but time consumption increases
Solution Approach 1:
The patent replaces the mechanical wet-lab experimental system with a computational simulation system. Instead of performing physical binding assays that require protein purification, ligand preparation, and time-consuming incubation and measurement steps, the method uses molecular docking and molecular dynamic simulations to predict binding activities, reducing experiment duration from days to hours while maintaining measurement precision through physics-based force fields and validated protocols
3Productivity
If molecular docking and molecular dynamic simulation are used to determine binding activities, then productivity is improved and time consumption is reduced, but method complexity increases
Solution Approach 1:
The patent segments the binding activity determination process into distinct computational stages: structure optimization of ligands and receptors, molecular docking to generate initial poses, molecular dynamic simulations to refine binding modes, and analysis of interaction energies. This segmentation allows each step to be optimized independently and facilitates parallel processing of multiple derivatives, improving productivity while making the complex methodology more manageable and reproducible
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively determines the binding activities of PBDEs derivatives to enoyl-ACP reductase, aligning with experimental results and providing a reliable, efficient means to evaluate their interactions.
Implementation Method 1
the enoyl-ACP reductase is the last step in fatty acid elongation, which is necessary to catalyze the reduction of enoyl-ACP to acyl carrier protein (ACP)
Implementation Method 2
analysing hydrogen bond, π-π stacking and halogen bond interaction between the ligand and the receptor
Implementation Method 3
analysing hydrogen bond, π-π stacking and halogen bond interaction between the ligand and the receptor
Implementation Method 4
analysing hydrogen bond, π-π stacking and halogen bond interaction between the ligand and the receptor
Data Source
AI summary
The present invention provide a method of constructing a ligand-receptor protein complex to determine the binding activity of different PBDEs derivatives to an enoyl-ACP reductase. The method comprises providing a ligand-receptor binding complex, molecular docking and performing molecular dynamic simulation. The present invention is able to determine the binding activity of PBDEs derivatives to the enoyl-ACP reductase comparable to the results obtained in vitro.